During the past decade, The Oncology Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip
Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
In terms of collaborators to trials, out of the total clinical trials conducted in "The Oncology Centre"
#1 collaborator was "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator, "National Medical Research Council (NMRC), Singapore" with 1 trials as a collaborator and "PharmaEngine" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at The Oncology Centre
According to Clinical.Site data, the most researched conditions in "The Oncology Centre" are
"Adult Soft Tissue Sarcoma" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Squamous Cell of Head and Neck" (1 trials). Many other conditions were trialed in "The Oncology Centre" in a lesser frequency.
Clinical Trials Intervention Types at The Oncology Centre
Most popular intervention types in "The Oncology Centre" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "EG12014" (1 trials), "Herceptin" (1 trials), "NBTXR3" (1 trials), "Nimotuzumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Oncology Centre
The vast majority of trials in "The Oncology Centre" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The Oncology Centre
Currently, there are NaN active trials in "The Oncology Centre".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The Oncology Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Oncology Centre, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".